Addressing hepatitis C-related discrimination in a post-cure world

解决治愈后世界中与丙型肝炎相关的歧视

• 批准号: DP200100941
• 负责人: Prof Kate Seear
• 金额: $ 39.35万
• 依托单位: La Trobe University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2023-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP200100941
• 关键词: Addressing; hepatitis; related; discrimination; post

This project aims to address the legal and policy dimensions of hepatitis C discrimination. Hepatitis C is a major public health challenge linked to profound discrimination, including in law and policy. Treatments introduced in 2016 improved cure rates; optimism about disease elimination is high, but questions remain about discrimination faced by those who are cured. This interdisciplinary project’s goal is to generate new knowledge about hepatitis C discrimination in a post-cure context, and identify opportunities for legal and policy reform. Expected outcomes of the project include better legal, social and policy outcomes for Australians cured of hepatitis C, significantly benefiting these individuals directly and society more broadly.

该项目旨在解决丙型肝炎歧视的法律的和政策方面的问题。丙型肝炎是一个重大的公共卫生挑战，与深刻的歧视有关，包括在法律和政策方面。2016年推出的治疗方法提高了治愈率;人们对消除疾病持高度乐观态度，但治愈者面临的歧视问题仍然存在。这个跨学科项目的目标是在治疗后的背景下产生关于丙型肝炎歧视的新知识，并确定法律的和政策改革的机会。该项目的预期成果包括为治愈丙型肝炎的澳大利亚人提供更好的法律的、社会和政策成果，使这些个人和社会更广泛地受益。